Literature DB >> 17011035

Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.

Nidia Alvarez-Rueda1, Ghislaine Behar, Virginie Ferré, Martine Pugnière, Françoise Roquet, Louis Gastinel, Catherine Jacquot, Jacques Aubry, Daniel Baty, Jacques Barbet, Stéphane Birklé.   

Abstract

Single-domain antibodies specific to methotrexate (MTX) were obtained after immunization of one llama (Llama glama). Specific VHH domains (V-D-J-REGION) were selected by panning from an immune-llama library using phage display technology. The antibody fragments specific to MTX were purified from Escherichia coli (C41 strain) periplasm by immobilized metal affinity chromatography with an expression level of around 10mg/L. A single band around 16,000Da corresponding to VHH fragments was found after analysis by SDS-PAGE and Western blotting, while competition ELISA demonstrated selective binding to soluble MTX. Surface plasmon resonance (SPR) analysis showed that anti-MTX VHH domains had affinities in the nanomolar range (29-515nM) to MTX-serum albumin conjugates. The genes encoding anti-MTX VHH were found by IMGT/V-QUEST to be similar to the previously reported llama and human IGHV germline genes. The V-D and D-J junction rearrangements in the seven anti-MTX CDR3 sequences indicate that they were originated from three distinct progenitor B cells. Our results demonstrate that camelid single-domain antibodies are capable of high affinity binding to low molecular weight hydrosoluble haptens. Furthermore, these anti-MTX VHH give new insights on how the antigen binding repertoire of llama single-domain antibody can provide combining sites to haptens in the absence of a VL. This type of single-domain antibodies offers advantages compared to murine recombinant antibodies in terms of production rate and sequence similarity to the human IGHV3 subgroup genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011035     DOI: 10.1016/j.molimm.2006.08.007

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  24 in total

1.  Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay.

Authors:  Hee-Joo Kim; Mark R McCoy; Zuzana Majkova; Julie E Dechant; Shirley J Gee; Sofia Tabares-da Rosa; Gualberto G González-Sapienza; Bruce D Hammock
Journal:  Anal Chem       Date:  2011-12-29       Impact factor: 6.986

2.  Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display.

Authors:  Klervi Even-Desrumeaux; Damien Nevoltris; Marie Noelle Lavaut; Karima Alim; Jean-Paul Borg; Stéphane Audebert; Brigitte Kerfelec; Daniel Baty; Patrick Chames
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

3.  An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.

Authors:  Sean W Fanning; James R Horn
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

4.  Competitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune response.

Authors:  Sofia Tabares-da Rosa; Martin Rossotti; Carmen Carleiza; Federico Carrión; Otto Pritsch; Ki Chang Ahn; Jerold A Last; Bruce D Hammock; Gualberto González-Sapienza
Journal:  Anal Chem       Date:  2011-08-29       Impact factor: 6.986

5.  An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.

Authors:  Abdolkarim Sheikhi; Mohammad Hojjat-Farsangi
Journal:  Hum Vaccin Immunother       Date:  2020-07-14       Impact factor: 3.452

6.  Structure and development of single domain antibodies as modules for therapeutics and diagnostics.

Authors:  Robert J Hoey; Hyeyoung Eom; James R Horn
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

7.  Structure and specificity of several triclocarban-binding single domain camelid antibody fragments.

Authors:  Sofia Tabares-da Rosa; Linda A Wogulis; Mark D Wogulis; Gualberto González-Sapienza; David K Wilson
Journal:  J Mol Recognit       Date:  2018-07-23       Impact factor: 2.137

8.  Development of a one-step immunoassay for triazophos using camel single-domain antibody-alkaline phosphatase fusion protein.

Authors:  Kai Wang; Zhiping Liu; Guochun Ding; Ji Li; Natalia Vasylieva; Qing X Li; Dongyang Li; Shirley J Gee; Bruce D Hammock; Ting Xu
Journal:  Anal Bioanal Chem       Date:  2019-02-01       Impact factor: 4.142

Review 9.  VHH antibodies: emerging reagents for the analysis of environmental chemicals.

Authors:  Candace S Bever; Jie-Xian Dong; Natalia Vasylieva; Bogdan Barnych; Yongliang Cui; Zhen-Lin Xu; Bruce D Hammock; Shirley J Gee
Journal:  Anal Bioanal Chem       Date:  2016-05-21       Impact factor: 4.142

Review 10.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.